Clinical Trials Directory

Trials / Sponsors / ImmunoVaccine Technologies, Inc. (IMV Inc.)

ImmunoVaccine Technologies, Inc. (IMV Inc.)

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer
Platinum-resistant Epithelial Ovarian Cancer
Phase 22022-08-05
RecruitingDPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relap
Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma
Phase 22021-06-18
Active Not RecruitingStudy of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in
Ovarian Cancer, Hepatocellular Carcinoma, Non-small Cell Lung Cancer
Phase 22018-12-21
UnknownStudy of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
Recurrent Epithelial Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Peritoneal Cancer
Phase 1 / Phase 22016-04-01
TerminatedA Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL
Diffuse Large B-Cell Lymphoma
Phase 22015-01-01
CompletedPhase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Canc
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
Phase 12013-08-23
CompletedPhase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cance
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
Phase 12011-12-01
CompletedA Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostat
Ovarian Neoplasms, Breast Neoplasms, Prostatic Neoplasms
Phase 12010-03-01